Recent advancements in exon-skipping therapies using antisense oligonucleotides and genome editing for the treatment of various muscular dystrophies
Expert Rev Mol Med . 2019 Oct 2;21:e5. doi: 10.1017/erm.2019.5.
Jaeho Hwang 1, Toshifumi Yokota 1 2
Affiliations expand
PMID: 31576784 DOI: 10.1017/erm.2019.5
https://pubmed.ncbi.nlm.nih.gov/31576784/
- Visite: 1820